Epstein Files Search

EFTA02153650Dataset 10

2012-11-296p1,638w

Subject: Early Tour 11.29.12

…vs 55c ests) (trading -8%) . Guess? midpoint Q4 eps view topped estimates & set 51.20/shr special div (trading +5%) EFTA_R1_00819392 EFTA02153650 • TiVo Q3 beats (posts profit on patent settlement) but guides for a O4 loss (trading -1.5%) • German unemployment rose for Eith straight month in November (jobless rate held at 6.9%) • Invensys announces Siemens to buy rail unit for £1.74bn, to return £625mn cash (trading +9%) • Kingfisher Q3 LIL sales light, profit in line…

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02153650.pdf

EFTA00386261Dataset 9

2013-07-319p3,206w

Subject: Early Tour 7.31.13

From: U

…6.7% after beating estimates and is now +52% in July, and Bayer opened lower due to "increasingly ambitious guidance" but buyers stepped in on the weakness and stock now +3.5% on the session. In M&A, Schneider announces a formal 502p cash & stock bid for Invensys and consensus still does not expect any competing bids to surface (SU FP trading +4.3% and ISYS LN trading 501p last). Busy macro day ahead with EFTA00386261 the ADP Employment, GDP…

https://www.justice.gov/epstein/files/DataSet%209/EFTA00386261.pdf

EFTA02135422Dataset 10

2013-06-128p2,020w

From: Ike Groff

…40%) • BAE Systems nominate former CBI head Carr as successor to Olver as chairman (trading +0.10%) • Severn Trent; Borealis lead consortium walk away from bid as deadline expires (trading -7.6%) • Generali sells minority stakes in Mexican companies to Seguros Banorte for $857.5mn (trading ) • Invensys: ex-dividend 76.70p and 4:5 stock consolidation takes effect today (ISYS LN trading - 3.4%) EFTA_R1_00783644 EFTA02135423 • MSCI classification changes: Greece (DM to EM), Qatar & UAE (FM to EM)…

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02135422.pdf

EFTA02122552Dataset 10

2013-11-0710p3,010w

Subject: Early Tour 11.7.13

…Morrisons Q3 IMS, LfL's miss, financial outlook maintained, low expectations vs peers (trading - 0.80%) • Aviva O3 IMS, progress in line, new business +14%, still early stage turnaround (trading -0.50%) • Invensys H1 revs and op profit broadly flat y/y, no interim div, no surprises near term (trading +0.20%) • Inmarsat O3 IMS revs light, costs higher on GX launch, sees tough 2014 in US, transition year (trading -5.0%) • Tate & Lyle H1 revs ahead, op income below…

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02122552.pdf